Evidence map›Paper›PMID 28970380›Full record

ArticlePharmacy (Basel, Switzerland)2016

Advanced Level Practice Education: UK Critical Care Pharmacists' Opinions in 2015.

Ruth E Warin, Richard S Bourne, Mark Borthwick, Greg Barton, Ian Bates

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The role of the pharmacist in the intensive care unit.Journal of the Intensive Care Society · 2019
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruth E WarinDepartments of Pharmacy and Critical Care, Sheffield Teaching Hospitals, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK. ruth.warin@sth.nhs.uk.
Richard S BourneDepartments of Pharmacy and Critical Care, Sheffield Teaching Hospitals, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK. Richard.bourne@sth.nhs.uk.ORCID 0000-0003-0893-525X
Mark BorthwickPharmacy Department, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK. Mark.borthwick@ouh.nhs.uk.
Greg BartonPharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Whiston Hospital, Warrington Road, Prescot L35 5DR, UK. greg.barton@sthk.nhs.uk.
Ian BatesDepartment of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. i.bates@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National UK standards for critical care highlight the need for clinical pharmacists to practice at an advanced level and above. The aim of this research paper was to describe the views of UK critical care pharmacists on the current provision of Advanced Level Practice (ALP) education and accreditation. It sought to identify whether there is a need for a national or regional training programme. A questionnaire was delivered electronically targeting UK critical care pharmacists. Whilst the response rate was low at 40% (166/411); the views expressed were representative of UK practitioners with the majority of responders meeting the national specifications for clinical pharmacist staffing in critical care areas. The responses highlighted work-based learning as the main resource for developing ALP and a lack of suitable training packages. The vast majority of pharmacists identified that a national or regional training programme was required for ALP. The results also identified the main barriers to undertaking ALP accreditation were lack of time, uncertainty regarding the process and its professional benefits and a lack of education and training opportunities. In conclusion, the responses clearly indicated that, for the necessary progression of critical care pharmacists to ALP, a national or regional training programme is required.

Indexed as

advanced practiceeducationpharmacy

Identifiers

PMID28970380
PMCPMC5419361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.